Utama › Aterosklerosis › Texas

Kajian klinikal Aterosklerosis di Texas

11 kajian untuk Aterosklerosis sedang mencari peserta di lokasi di Texas.

Bandar di Texas

Teks kajian rasmi (Bahasa Inggeris)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
dan 2 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Southwest Family Medicine Associates, Dallas
East Texas Cardiology PA, Houston
Cardiovascular Specialists of Willowbrook, Houston
dan 1 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

PharmaTex Research, Amarillo
St. David's Heart & Vascular PLLC dba Austin Heart, Austin
Velocity Clinical Research, Austin, Austin
dan 18 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

PharmaTex Research, LLC, Amarillo
Austin Heart, Austin
Velocity Clinical Research - Austin, Austin
dan 22 lagi

Mengambil pesertaFasa 3

Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

PharmaTex Research, LLC, Amarillo
Pulse Care Heart and Vascular, Carrollton
DM Clinical Research - Dallas, Tomball

Mengambil pesertaFasa 2

Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Cussimanio Research Group LLC, Austin
Research Management, Inc., Austin
MW Clinical Research Center, Beaumont
dan 22 lagi

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Amarillo
Research Site, Beaumont
Research Site, Brownsville
dan 33 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

PharmaTex Research LLC, Amarillo
Kelsey Seybold Research Foundation, Houston
Northwest Houston Clinical Research PLLC, Tomball

Mengambil pesertaFasa 3

Umur 18 hingga 80 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

Plano Primary Care Clinic, Allen
Pharma Tex Research, Amarillo
SW Family Medicine Associates, Dallas
dan 8 lagi

Mengambil pesertaFasa 3

Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Mengambil pesertaFasa 4

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT02915198

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

UT Health Houston, Houston

Mengambil pesertaFasa 2

Umur 40 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT05488431

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.